Page last updated: 2024-08-21

isoxazoles and Interstitial Cell Tumor

isoxazoles has been researched along with Interstitial Cell Tumor in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andò, S; Bonofiglio, D; Catalano, S; Giordano, C; Gu, G; Lanzino, M; Malivindi, R; Panno, ML; Panza, S; Sisci, D1
Andò, S; Barone, I; Bonofiglio, D; Bossi, G; Catalano, S; Giordano, C; Lanzino, M; Malivindi, R; Mauro, L; Panza, S; Sirianni, R; Sisci, D1

Other Studies

2 other study(ies) available for isoxazoles and Interstitial Cell Tumor

ArticleYear
Farnesoid X receptor, through the binding with steroidogenic factor 1-responsive element, inhibits aromatase expression in tumor Leydig cells.
    The Journal of biological chemistry, 2010, Feb-19, Volume: 285, Issue:8

    Topics: Animals; Aromatase; Cathartics; Chenodeoxycholic Acid; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; HeLa Cells; Hep G2 Cells; Humans; Isoxazoles; Leydig Cell Tumor; Leydig Cells; Male; Mice; Neoplasm Proteins; Rats; Rats, Inbred F344; Receptors, Cytoplasmic and Nuclear; Response Elements; Steroidogenic Factor 1

2010
Inhibition of Leydig tumor growth by farnesoid X receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy.
    International journal of cancer, 2013, May-15, Volume: 132, Issue:10

    Topics: Animals; Antineoplastic Agents; Apoptosis; Aromatase; Cell Proliferation; Down-Regulation; Electrophoresis, Polyacrylamide Gel; Electrophoretic Mobility Shift Assay; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Immunoblotting; Immunoprecipitation; In Situ Nick-End Labeling; Isoxazoles; Leydig Cell Tumor; Male; Mice; Mice, Nude; NF-kappa B; p21-Activated Kinases; Random Allocation; Real-Time Polymerase Chain Reaction; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; Testicular Neoplasms; Transcriptional Activation; Tumor Suppressor Protein p53; Up-Regulation; Xenograft Model Antitumor Assays

2013